首页|SZT2基因变异所致发育性癫痫性脑病18型患儿临床及遗传学分析

SZT2基因变异所致发育性癫痫性脑病18型患儿临床及遗传学分析

扫码查看
目的 探讨SZT2基因变异所致发育性癫痫性脑病18型(DEE18)患儿临床表型及遗传学特征。方法 收集2020年3月、2023年7月在临沂市人民医院小儿神经内科就诊的2例SZT2基因相关DEE18患儿的临床资料,应用全外显子测序(WES)及Sanger测序法对患儿及其父母进行基因检测,使用SWISS-MODEL软件对筛选出的SZT2基因变异进行蛋白质3D建模。结果 2例患儿均存在重度全面发育迟缓、癫痫发作及孤独症表现,伴有大头畸形、特殊面容、全身肌张力低下,影像学检查提示胼胝体畸形、透明膈腔持续存在,视频脑电图示背景活动慢、局灶性放电。其中患儿1自幼易惊且身材瘦小;患儿2免疫缺陷且癫痫成簇发作。WES结果显示患儿1携带SZT2基因c。5811G>A(p。W1937X)(父源)和 c。9269delG(p。S3090Ifs*94)(母源)复合杂合变异,患儿 2 携带 c。6302A>C(p。H2101P)(父源)和c。7584dupA(p。E2529Rfs*20)(母源)复合杂合变异,2例患儿的父母临床表型均正常。上述4种变异为目前国内外尚未报道的新变异。根据美国医学遗传学与基因组学学会指南评估:p。S3090Ifs*94为致病性变异,p。W1937X为致病性变异,p。E2529Rfs*20为可能致病性变异,p。H2101P为意义未明确变异。3D建模发现p。H2101P变异可导致编码的第2 101位氨基酸周围氢键发生明显改变,蛋白质稳定性降低;其余3种变异可导致肽链提前截断,蛋白质结构发生明显改变。结论 SZT2基因变异引起的DEE 18多为常染色体隐性遗传疾病,临床表现为全面发育迟缓、癫痫发作、孤独症、颅面部畸形、全身肌张力低下、脑电图异常放电、胼胝体畸形、透明膈腔持续存在、易惊、身材瘦小和免疫缺陷。4种SZT2基因相关的新变异可能为本组DEE 18患儿的遗传学病因。
Clinical and genetic analysis of children with developmental and epileptic encephalopathy 18 caused by SZT2 gene variants
Objective To investigate the clinical phenotype and genetic characteristics of developmental epileptic encephalopathy 18(DEE18)caused by SZT2 gene variants.Methods Clinical data of 2 children with SZT2 related DEE18 who visited the Department of Pediatric Neurology,Linyi People's Hospital in March 2020 and July 2023 were collected.The whole exome sequencing(WES)and Sanger sequencing were applied to verify the child and their parents.SWISS-MODEL software was used to perform protein 3D modeling for the selected SZT2gene variants.Results Both of the 2 cases showed severe global developmental delay,epileptic seizures,autism,megacephaly,facial deformity,hypotonia,corpus callosum malformation,persistent cavum septum pellucidum,and slow background activity and focal discharge in video electroencephalography.Case 1 was easy to startle and thin in stature;case 2 had immune deficiency and clustered seizures.WES results showed that case 1 carried a compound heterozygous variant of c.5811G>A(p.W1937X)(paternal)and c.9269delG(p.S3090Ifs*94)(maternal),while case 2 carried a compound heterozygous variant of c.6302A>C(p.H2101P)(paternal)and c.7584dupA(p.E2529Rfs*20)(maternal),the parents of both patients with normal clinical phenotypes.The 4 mutations mentioned above were novel variations that had not yet been reported domestically or internationally.According to the American College of Medical Genetics and Genomics variant classification criteria and guidelines,the p.S3090Ifs*94 variant was interpreted as pathogenic;p.W1937X variant was interpreted as pathogenic;p.E2529Rfs*20 variant was interpreted as likely pathogenic;p.H2101P variant was interpreted as uncertain significance.3D modeling showed that the variant of p.H2101P resulted in a significant change in the hydrogen bond around the 2 101st amino acid encoded,leading to a decrease in protein stability.The other 3 variants led to early truncation of peptide chain and obvious changes in protein structure.Conclusions DEE18 caused by SZT2 gene mutation is mainly an autosome recessive genetic disease,and its clinical manifestations include global developmental delay,epileptic seizures,autism,craniofacial malformation,hypotonia,epileptic discharge,corpus callosum malformation,persistent cavum septum pellucidum,shock,small and thin stature,and immune deficiency.Four novel variants related to the SZT2 gene may be the genetic etiology of DEE18 patients in this study.

EpilepsyDevelopmental disabilitiesSZT2 geneMissense mutationCongenital abnormalitiesWhole exome sequencing

张新、朱丽萍、杨莉、邱世彦、徐那、韩玉增、李玉芬

展开 >

锦州医科大学研究生培养基地临沂市人民医院小儿神经内科,临沂 276003

临沂市人民医院小儿神经内科,临沂 276003

癫痫 发育障碍 SZT2基因 错义变异 先天畸形 全外显子测序

临沂市重点研发计划

2023YX0005

2024

中华神经科杂志
中华医学会

中华神经科杂志

CSTPCD北大核心
影响因子:1.329
ISSN:1006-7876
年,卷(期):2024.57(2)
  • 22